Photo of Seán Finan

Seán Finan advises clients in the life sciences sector on a broad range of regulatory and commercial matters, including MDD/MDR classification, due diligence on life sciences regulatory matters and policy implementation.

Seán is a member of the firm’s Disability and Mental Health affinity group.

The UK government has proposed legislation to open the way for gene‑edited food products in England.  The Genetic Technology (Precision Breeding) Bill (“Precision Breeding Bill”) sets out a new regulatory regime that may provide a faster and easier path to market for certain gene-edited plants, animals and derived products.

Continue Reading UK Draft Bill Permits ‘Precision Bred’ Gene-Edited Plants, Animals and Products